Ilich Herbert De La Hoz Siegler
A5039834312- COVID-19 Clinical Research Studies
- COVID-19 epidemiological studies
- COVID-19 and healthcare impacts
- SARS-CoV-2 and COVID-19 Research
- Venous Thromboembolism Diagnosis and Management
- Healthcare cost, quality, practices
- Viral gastroenteritis research and epidemiology
- Health Systems, Economic Evaluations, Quality of Life
- Vaccine Coverage and Hesitancy
- Platelet Disorders and Treatments
- Pharmaceutical Economics and Policy
- Pneumonia and Respiratory Infections
- Heparin-Induced Thrombocytopenia and Thrombosis
- Dermatological and COVID-19 studies
Fundación Universitaria Sanitas
2022-2023
To evaluate the association between Colombia's third wave when Mu variant was predominant epidemiologically (until 75%) in Colombia and COVID-19 all-cause in-hospital mortality.In this retrospective cohort, we included hospitalized patients ≥18 years with SARS-CoV-2 infection March 2020 to September 2021 ten hospitals from three cities Colombia. Description analysis, survival, multivariate Cox regression analyses were performed epidemic mortality.A total of 25,371 included. The...
Introduction: recent studies have reported the occurrence of thrombotic phenomena or coagulopathy in patients with COVID-19.There are divergent positions regarding prevention, diagnosis, and treatment these phenomena, current clinical practice is based solely on deductions by extension from retrospective studies, case series, observational international guidelines developed prior to pandemic.Objective: generate a group recommendations diagnosis management complications associated...
In recent months, rare cases of thrombosis at unusual sites associated with thrombocytopenia, occurring within a typical risk window (i.e., 4-28 days) after receiving SARS CoV2 vaccines, have been reported. Healthcare professionals should be prepared to detect these on time. The Expert Panel the Knowledge Management and Transfer Network conducted free search related literature. With available information clinical expertise working group, we formulated, reviewed, endorsed recommendations for...
Objectives: To evaluate the association between Colombia's third wave when Mu variant was predominant in Colombia and COVID-19 all-cause in-hospital mortality.Methods: In this retrospective cohort, we included hospitalized patients ≥18 years with SARS-CoV-2 infection March 2020 to September 2021 ten hospitals from three cities Colombia. Description analysis, survival, multivariate Cox regression analyses were performed epidemic mortality.Results: A total of 25,371 included. The...
Introduction: Due to the emergence of SARS-CoV-2 coronavirus since December 2019, a large volume scientific production has been generated, in some cases uncertain or controversial, especially pharmacological management patients with this infection; therefore, it is considered relevant search for methodological alternatives carry out its rigorous, systematic and quality synthesis, but less execution time lower cost. Objective: To present available evidence regarding people suspected diagnosed...
Background: The third epidemic wave reported the greatest number of deaths related to SARS-CoV-2 in Colombia. In this wave, Mu variant was predominant 75% cases. Therefore, we evaluated association between Colombia's and COVID-19 all-cause in-hospital mortality.Methods: retrospective cohort, included hospitalized patients ≥18 years with infection March 2020 September 2021 ten hospitals from three cities Description analysis, survival, multivariate Cox regression analyses were performed...